TLR2, TLR4 AND MyD88 mediate allergic airway disease (AAD) and Streptococcus pneumoniae-induced suppression of AAD

- Thorburn, Alison N., Tseng, Hsin-Yi, Donovan, Chantal, Hansbro, Nicole G., Jarnicki, Andrew G., Foster, Paul S., Gibson, Peter G., Hansbro, Philip M.

Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites

- Thorburn, Alison N., McKenzie, Craig I., Chevalier, Nina, Tan, Jian K., Marinõ, Eliana, Moore, Rob J., Wong, Lee, McConville, Malcolm J., Tull, Dedreia L., Wood, Lisa G., Murphy, Vanessa E., Mattes, Joerg, Shen, Sj, Gibson, Peter G., MacKay, Charles R., Stanley, Dragana, MacIa, Laurence, Mason, Linda J., Roberts, Laura K., Wong, Connie H. Y., Shim, Raymond, Robert, Remy

Inflammation and lymphopenia trigger autoimmunity by suppression of IL-2-controlled regulatory T cell and increase of IL-21-mediated effector T cell expansion

- Chevalier, Nina, Thorburn, Alison N., Macia, Laurence, Tan, Jian, Juglair, Laurent, Yagita, Hideo, Yu, Di, Hansbro, Philip M., MacKay, Charles R.

Pneumococcal components induce regulatory T cells that attenuate the development of allergic airways disease by deviating and suppressing the immune response to allergen

- Thorburn, Alison N., Brown, Alexandra C., Nair, Prema M., Chevalier, Nina, Foster, Paul S., Gibson, Peter G., Hansbro, Philip M.

Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells

- Thorburn, Alison N., Foster, Paul S., Gibson, Peter G., Hansbro, Philip M.

Harnessing regulatory T cells to suppress asthma: from potential to therapy

- Thorburn, Alison N., Hansbro, Philip M.

Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease

- Thorburn, Alison N., O'Sullivan, Brendan J, Thomas, Ranjeny, Kumar, Rakesh K., Foster, Paul S., Gibson, Peter G., Hansbro, Philip M.

Pneumococcal vaccines for allergic airways diseases

- Thorburn, Alison N., Hansbro, Philip M., Gibson, Peter G.